From multiple pills per day to one treatment per month: progress in HIV medication made possible by pharma collaborations Unprecedented collaborations between different pharmaceutical companies have resulted in extraordinary progress for HIV patients over the past four decades. From […] December 5, 2022 · Janssen Pharmaceutica
From pattern to patient: microbiome research needs to bridge the gap to the clinic The microbiome has been a trending scientific topic in recent years. Researchers have uncovered correlations between the human microbiome and […] September 7, 2022 · BioVox
VC opportunities for impact in the face of climate disaster Venture capitalists have a vital role to play in guiding our planet’s future. By investing in technological advances that remediate […] September 7, 2022 · V-Bio Ventures
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform • Closing on € 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs […] August 25, 2022 · V-Bio Ventures
Bacterial biofilms: cooperative bugs cling to food surfaces even after cleaning Current cleaning and disinfection practices in food industries are insufficient to destroy unwanted bacteria lurking on surfaces, according to recent […] August 17, 2022 · SciMingo
miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test Leuven, Belgium, 2 May 2022 – miDiagnostics, a fast-growing POC diagnostics company announces the launch of its CE-IVD certified ultra-fast COVID-19 PCR […] May 2, 2022 · Turnstone Communications
miDiagnostics welcomes Nicolas De Clercq as its new Chief Financial Officer Leuven, Belgium, 30 March 2022 – miDiagnostics, a fast-growing POC diagnostics company backed by Belgian Family Offices, announces today that Nicolas De […] March 30, 2022 · Turnstone Communications
Antimicrobial Resistance – the hidden killer we’re ignoring Antimicrobial Resistance has become an enormous challenge for global health, yet remains largely ignored by companies. As this deadly race […] March 16, 2022 · V-Bio Ventures
Long COVID: what it means for the life sciences industry and other chronic conditions Long COVID is a less talked-about aspect of the COVID-19 pandemic, yet its impact on society is already profound. Although […] December 15, 2021 · V-Bio Ventures
Moderna: from secretive platform company to vaccine superstar Moderna Therapeutics has never really been a typical biotech. Sure, nowadays it is world famous thanks to its COVID-19 vaccine, […] June 23, 2021 · V-Bio Ventures
Malaria vaccine candidate shows promise for African children Despite decades of research, scientists have so far been unable to develop a fully effective vaccine for malaria. Now, a […] June 16, 2021 · BioVox
Lessons learned from COVID-19: how do we prepare for the next pandemic? Although the crisis has not yet passed, COVID-19 has already taught us many valuable lessons. This past year has tested […] March 10, 2021 · Turnstone Communications
Record-breaking pollen levels linked to increased risk of COVID-19 Increased pollen concentrations are correlated with higher rates of COVID-19. Hot on the heels of record-breaking European pollen counts, this […] March 10, 2021 · BioVox
Preventive saliva test for detecting the COVID-19 virus is now available to companies and organizations Ghent, Belgium, 23 February 2021 – The Ghent company Biogazelle and the medical laboratory Labo Nuytinck (Ghent, Evergem), together with […] February 23, 2021 · Turnstone Communications
One year of COVID-19: a look back at 2020 and where we are now One year on from the emergence of SARS-COV-2 in Wuhan, China, this novel coronavirus continues to devastate the world. Since […] January 27, 2021 · BioVox